BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roderfeld M, Weiskirchen R, Wagner S, Berres M, Henkel C, Grötzinger J, Gressner AM, Matern S, Roeb E. Inhibition of hepatic fibrogenesis by matrix metalloproteinase‐9 mutants in mice. FASEB j 2006;20:444-54. [DOI: 10.1096/fj.05-4828com] [Cited by in Crossref: 103] [Cited by in F6Publishing: 105] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Lan L, Chen Y, Sun C, Sun Q, Hu J, Li D. Transplantation of bone marrow-derived hepatocyte stem cells transduced with adenovirus-mediated IL-10 gene reverses liver fibrosis in rats. Transpl Int. 2008;21:581-592. [PMID: 18282246 DOI: 10.1111/j.1432-2277.2008.00652.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
2 Roderfeld M, Weiskirchen R, Atanasova S, Gressner AM, Preissner KT, Roeb E, Kanse SM. Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells. Liver International 2009;29:686-91. [DOI: 10.1111/j.1478-3231.2008.01897.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
3 Afratis NA, Klepfish M, Karamanos NK, Sagi I. The apparent competitive action of ECM proteases and cross-linking enzymes during fibrosis: Applications to drug discovery. Advanced Drug Delivery Reviews 2018;129:4-15. [DOI: 10.1016/j.addr.2018.03.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
4 Campana L, Iredale J. Matrix Metalloproteinases and Their Inhibitors. Stellate Cells in Health and Disease. Elsevier; 2015. pp. 107-24. [DOI: 10.1016/b978-0-12-800134-9.00007-5] [Cited by in Crossref: 7] [Article Influence: 1.0] [Reference Citation Analysis]
5 Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215-233. [PMID: 19167326 DOI: 10.1016/j] [Cited by in F6Publishing: 153] [Reference Citation Analysis]
6 Liu X, Wu Y, Yang Y, Li W, Huang C, Meng X, Li J. Role of NLRC5 in progression and reversal of hepatic fibrosis. Toxicology and Applied Pharmacology 2016;294:43-53. [DOI: 10.1016/j.taap.2016.01.012] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
7 Liu W, Hou T, Shi W, Guo D, He H. Hepatoprotective effects of selenium-biofortified soybean peptides on liver fibrosis induced by tetrachloromethane. Journal of Functional Foods 2018;50:183-91. [DOI: 10.1016/j.jff.2018.09.034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
8 Mazo DF, de Oliveira MG, Pereira IV, Cogliati B, Stefano JT, de Souza GF, Rabelo F, Lima FR, Ferreira Alves VA, Carrilho FJ. S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. Drug Des Devel Ther. 2013;7:553-563. [PMID: 23843692 DOI: 10.2147/dddt.s43930] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
9 Gifre-Renom L, Seras-Franzoso J, Rafael D, Andrade F, Cano-Garrido O, Martinez-Trucharte F, Ugarte-Berzal E, Martens E, Boon L, Villaverde A, Opdenakker G, Schwartz S Jr, Arís A, Garcia-Fruitós E. The Biological Potential Hidden in Inclusion Bodies. Pharmaceutics 2020;12:E157. [PMID: 32075316 DOI: 10.3390/pharmaceutics12020157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Roderfeld M. Matrix metalloproteinase functions in hepatic injury and fibrosis. Matrix Biol. 2018;68-69:452-462. [PMID: 29221811 DOI: 10.1016/j.matbio.2017.11.011] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 11.0] [Reference Citation Analysis]
11 Tokunaga Y, Osawa Y, Ohtsuki T, Hayashi Y, Yamaji K, Yamane D, Hara M, Munekata K, Tsukiyama-Kohara K, Hishima T, Kojima S, Kimura K, Kohara M. Selective inhibitor of Wnt/β-catenin/CBP signaling ameliorates hepatitis C virus-induced liver fibrosis in mouse model. Sci Rep 2017;7:325. [PMID: 28336942 DOI: 10.1038/s41598-017-00282-w] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
12 Liu Y, Xia JR, Cai XG. Effect of siRNA-mediated down-regulation of receptor for advanced glycation end products on expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in rat hepatic stellate cells and hepatic fibrosis. Shijie Huaren Xiaohua Zazhi 2015; 23(19): 3012-3021 [DOI: 10.11569/wcjd.v23.i19.3012] [Reference Citation Analysis]
13 Ge WS, Wu JX, Fan JG, Wang YJ, Chen YW. Inhibition of high-mobility group box 1 expression by siRNA in rat hepatic stellate cells. World J Gastroenterol 2011; 17(36): 4090-4098 [PMID: 22039322 DOI: 10.3748/wjg.v17.i36.4090] [Cited by in CrossRef: 34] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
14 Stefano JT, Pereira IV, Torres MM, Bida PM, Coelho AM, Xerfan MP, Cogliati B, Barbeiro DF, Mazo DF, Kubrusly MS, D'Albuquerque LA, Souza HP, Carrilho FJ, Oliveira CP. Sorafenib prevents liver fibrosis in a non-alcoholic steatohepatitis (NASH) rodent model. Braz J Med Biol Res 2015;48:408-14. [PMID: 25714891 DOI: 10.1590/1414-431X20143962] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.9] [Reference Citation Analysis]
15 Fallowfield JA. Therapeutic targets in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;300:G709-G715. [PMID: 21233278 DOI: 10.1152/ajpgi.00451.2010] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 7.8] [Reference Citation Analysis]
16 Gifre-Renom L, Ugarte-Berzal E, Martens E, Boon L, Cano-Garrido O, Martínez-Núñez E, Luque T, Roca-Pinilla R, Conchillo-Solé Ò, Ferrer-Miralles N, Villaverde A, Opdenakker G, Garcia-Fruitós E, Arís A. Recombinant Protein-Based Nanoparticles: Elucidating their Inflammatory Effects In Vivo and their Potential as a New Therapeutic Format. Pharmaceutics 2020;12:E450. [PMID: 32414218 DOI: 10.3390/pharmaceutics12050450] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Barreyro FJ, Holod S, Finocchietto PV, Camino AM, Aquino JB, Avagnina A, Carreras MC, Poderoso JJ, Gores GJ. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis. Liver Int. 2015;35:953-966. [PMID: 24750664 DOI: 10.1111/liv.12570] [Cited by in Crossref: 164] [Cited by in F6Publishing: 153] [Article Influence: 20.5] [Reference Citation Analysis]
18 Iredale JP, Thompson A, Henderson NC. Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation. Biochim Biophys Acta. 2013;1832:876-883. [PMID: 23149387 DOI: 10.1016/j.bbadis.2012.11.002] [Cited by in Crossref: 146] [Cited by in F6Publishing: 134] [Article Influence: 14.6] [Reference Citation Analysis]
19 Yang JD, Nakamura I, Roberts LR. The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol 2011;21:35-43. [PMID: 20946957 DOI: 10.1016/j.semcancer.2010.10.007] [Cited by in Crossref: 216] [Cited by in F6Publishing: 207] [Article Influence: 18.0] [Reference Citation Analysis]
20 Ma X, Xu L, Wang S, Chen H, Xu J, Li X, Ning G. Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis. Lab Invest. 2009;89:903-914. [PMID: 19488034 DOI: 10.1038/labinvest] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Vainshtein JM, Kabarriti R, Mehta KJ, Roy-Chowdhury J, Guha C. Bone marrow-derived stromal cell therapy in cirrhosis: clinical evidence, cellular mechanisms, and implications for the treatment of hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2014;89:786-803. [PMID: 24969793 DOI: 10.1016/j.ijrobp.2014.02.017] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
22 Ramachandran P, Iredale JP. Reversibility of liver fibrosis. Ann Hepatol. 2009;8:283-291. [PMID: 20009126 DOI: 10.1016/s1665-2681(19)31740-5] [Cited by in Crossref: 69] [Cited by in F6Publishing: 1] [Article Influence: 5.8] [Reference Citation Analysis]
23 Liang YJ, Luo J, Yuan Q, Zheng D, Liu YP, Shi L, Zhou Y, Chen AL, Ren YY, Sun KY. New insight into the antifibrotic effects of praziquantel on mice in infection with Schistosoma japonicum. PLoS One. 2011;6:e20247. [PMID: 21629648 DOI: 10.1371/journal.pone.0020247] [Cited by in Crossref: 45] [Cited by in F6Publishing: 47] [Article Influence: 4.1] [Reference Citation Analysis]
24 Thomas JA, Pope C, Wojtacha D, Robson AJ, Gordon-Walker TT, Hartland S, Ramachandran P, Van Deemter M, Hume DA, Iredale JP. Macrophage therapy for murine liver fibrosis recruits host effector cells improving fibrosis, regeneration, and function. Hepatology. 2011;53:2003-2015. [PMID: 21433043 DOI: 10.1002/hep.24315] [Cited by in Crossref: 205] [Cited by in F6Publishing: 199] [Article Influence: 18.6] [Reference Citation Analysis]
25 Cong M, Liu T, Wang P, Fan X, Yang A, Bai Y, Peng Z, Wu P, Tong X, Chen J. Antifibrotic effects of a recombinant adeno-associated virus carrying small interfering RNA targeting TIMP-1 in rat liver fibrosis. Am J Pathol. 2013;182:1607-1616. [PMID: 23474083 DOI: 10.1016/j.ajpath.2013.01.036] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
26 Gieling RG, Wallace K, Han YP. Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1324-G1331. [PMID: 19342509 DOI: 10.1152/ajpgi.90564.2008] [Cited by in Crossref: 155] [Cited by in F6Publishing: 156] [Article Influence: 11.9] [Reference Citation Analysis]
27 Belinsky GS, Parke AL, Huang Q, Blanchard K, Jayadev S, Stoll R, Rothe M, Achenie LEK, Gupta RR, Wu GY, Rosenberg DW. The Contribution of Methotrexate Exposure and Host Factors on Transcriptional Variance in Human Liver. Toxicological Sciences 2007;97:582-94. [DOI: 10.1093/toxsci/kfm067] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
28 Birukawa NK, Murase K, Sato Y, Kosaka A, Yoneda A, Nishita H, Fujita R, Nishimura M, Ninomiya T, Kajiwara K, Miyazaki M, Nakashima Y, Ota S, Murakami Y, Tanaka Y, Minomi K, Tamura Y, Niitsu Y. Activated hepatic stellate cells are dependent on self-collagen, cleaved by membrane type 1 matrix metalloproteinase for their growth. J Biol Chem. 2014;289:20209-20221. [PMID: 24867951 DOI: 10.1074/jbc.m113.544494] [Cited by in Crossref: 23] [Cited by in F6Publishing: 10] [Article Influence: 2.9] [Reference Citation Analysis]
29 Wu SM, Li TH, Yun H, Ai HW, Zhang KH. miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT/mTOR Signaling. Yonsei Med J. 2019;60:561-569. [PMID: 31124340 DOI: 10.3349/ymj.2019.60.6.561] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
30 Ghiassi-Nejad Z, Friedman SL. Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol. 2008;2:803-816. [PMID: 19090740 DOI: 10.1586/17474124.2.6.803] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 4.9] [Reference Citation Analysis]
31 Pellicoro A, Ramachandran P, Iredale JP, Fallowfield JA. Liver fibrosis and repair: immune regulation of wound healing in a solid organ. Nat Rev Immunol. 2014;14:181-194. [PMID: 24566915 DOI: 10.1038/nri3623] [Cited by in Crossref: 652] [Cited by in F6Publishing: 628] [Article Influence: 81.5] [Reference Citation Analysis]
32 Iimuro Y, Brenner DA. Matrix metalloproteinase gene delivery for liver fibrosis. Pharm Res. 2008;25:249-258. [PMID: 17577645 DOI: 10.1007/s11095-007-9311-7] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
33 Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655-1669. [PMID: 18471545 DOI: 10.1053/j.gastro.2008.03.003] [Cited by in Crossref: 1758] [Cited by in F6Publishing: 1753] [Article Influence: 125.6] [Reference Citation Analysis]
34 Bueno M, Salgado S, Beas-Zárate C, Armendariz-Borunda J. Urokinase-type plasminogen activator gene therapy in liver cirrhosis is mediated by collagens gene expression down-regulation and up-regulation of MMPs, HGF and VEGF. J Gene Med. 2006;8:1291-1299. [PMID: 16958060 DOI: 10.1002/jgm.961] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
35 Chen P, Han Z, Yang P, Zhu L, Hua Z, Zhang J. Loss of clock gene mPer2 promotes liver fibrosis induced by carbon tetrachloride. Hepatol Res 2010;40:1117-27. [PMID: 20880056 DOI: 10.1111/j.1872-034X.2010.00695.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
36 Pelz S, Stock P, Brückner S, Christ B. A methionine-choline-deficient diet elicits NASH in the immunodeficient mouse featuring a model for hepatic cell transplantation. Exp Cell Res 2012;318:276-87. [PMID: 22108588 DOI: 10.1016/j.yexcr.2011.11.005] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]
37 Ding Z, Kng Y, Yang H, Ke Z, Zhuo L. An orally available small imidazolium salt ameliorates inflammation and fibrosis in a murine model of cholestasis. Lab Invest 2011;91:752-63. [DOI: 10.1038/labinvest.2011.11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
38 Zhao X, Wang B, Li X, Wang T. Newly proposed fibrosis staging criterion for assessing carbon tetrachloride- and albumin complex-induced liver fibrosis in rodents. Pathology International 2008;58:580-8. [DOI: 10.1111/j.1440-1827.2008.02274.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
39 Seifert A, Düsterhöft S, Wozniak J, Koo CZ, Tomlinson MG, Nuti E, Rossello A, Cuffaro D, Yildiz D, Ludwig A. The metalloproteinase ADAM10 requires its activity to sustain surface expression. Cell Mol Life Sci 2021;78:715-32. [PMID: 32372373 DOI: 10.1007/s00018-020-03507-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Mormone E, George J, Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact. 2011;193:225-231. [PMID: 21803030 DOI: 10.1016/j.cbi.2011.07.001] [Cited by in Crossref: 171] [Cited by in F6Publishing: 163] [Article Influence: 15.5] [Reference Citation Analysis]
41 Zvibel I, Bar-Zohar D, Kloog Y, Oren R, Reif S. The effect of Ras inhibition on the proliferation, apoptosis and matrix metalloproteases activity in rat hepatic stellate cells. Dig Dis Sci 2008;53:1048-53. [PMID: 17934818 DOI: 10.1007/s10620-007-9984-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
42 Muddu AK, Guha IN, Elsharkawy AM, Mann DA. Resolving fibrosis in the diseased liver: translating the scientific promise to the clinic. Int J Biochem Cell Biol 2007;39:695-714. [PMID: 17110155 DOI: 10.1016/j.biocel.2006.10.006] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 2.2] [Reference Citation Analysis]
43 Omar R, Yang J, Liu H, Davies NM, Gong Y. Hepatic Stellate Cells in Liver Fibrosis and siRNA-Based Therapy. Rev Physiol Biochem Pharmacol 2016;172:1-37. [PMID: 27534415 DOI: 10.1007/112_2016_6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
44 Yang F, Luo L, Zhu ZD, Zhou X, Wang Y, Xue J, Zhang J, Cai X, Chen ZL, Ma Q, Chen YF, Wang YJ, Luo YY, Liu P, Zhao L. Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway in Vitro and in Vivo. Front Pharmacol 2017;8:929. [PMID: 29311932 DOI: 10.3389/fphar.2017.00929] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
45 Gifre-Renom L, Carratalá JV, Parés S, Sánchez-García L, Ferrer-Miralles N, Villaverde A, Bach A, Garcia-Fruitós E, Arís A. Potential of MMP-9 based nanoparticles at optimizing the cow dry period: pulling apart the effects of MMP-9 and nanoparticles. Sci Rep 2020;10:11299. [PMID: 32647244 DOI: 10.1038/s41598-020-67176-2] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Mu Y, Ogawa T, Kawada N. Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine–choline-deficient diet. Lab Invest 2010;90:245-56. [DOI: 10.1038/labinvest.2009.123] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 2.6] [Reference Citation Analysis]
47 Bellayr IH, Mu X, Li Y. Biochemical insights into the role of matrix metalloproteinases in regeneration: challenges and recent developments. Future Med Chem 2009;1:1095-111. [PMID: 20161478 DOI: 10.4155/fmc.09.83] [Cited by in Crossref: 65] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
48 Duval F, Moreno-Cuevas JE, González-Garza MT, Rodríguez-Montalvo C, Cruz-Vega DE. Protective mechanisms of medicinal plants targeting hepatic stellate cell activation and extracellular matrix deposition in liver fibrosis. Chin Med 2014;9:27. [PMID: 25606051 DOI: 10.1186/s13020-014-0027-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
49 Henkel C, Roderfeld M, Weiskirchen R, Berres ML, Hillebrandt S, Lammert F, Meyer HE, Stühler K, Graf J, Roeb E. Changes of the hepatic proteome in murine models for toxically induced fibrogenesis and sclerosing cholangitis. Proteomics 2006;6:6538-48. [PMID: 17109383 DOI: 10.1002/pmic.200600580] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
50 Ma X, Xu L, Wang S, Chen H, Xu J, Li X, Ning G. Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis. Lab Invest 2009;89:903-14. [PMID: 19488034 DOI: 10.1038/labinvest.2009.51] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
51 Roderfeld M, Koc A, Rath T, Blöcher S, Tschuschner A, Akineden Ö, Fischer M, von Gerlach S, Goethe R, Eckelt E, Meens J, Bülte M, Basler T, Roeb E. Induction of matrix metalloproteinases and TLR2 and 6 in murine colon after oral exposure to Mycobacterium avium subsp. paratuberculosis. Microbes Infect 2012;14:545-53. [PMID: 22289202 DOI: 10.1016/j.micinf.2012.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
52 Song M, Song Z, Barve S, Zhang J, Chen T, Liu M, Arteel GE, Brewer GJ, McClain CJ. Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 2008;325:409-16. [PMID: 18299419 DOI: 10.1124/jpet.107.131227] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
53 Sanz-garcía C, Fernández-iglesias A, Gracia-sancho J, Arráez-aybar LA, Nevzorova YA, Cubero FJ. The Space of Disse: The Liver Hub in Health and Disease. Livers 2021;1:3-26. [DOI: 10.3390/livers1010002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
54 Mardpour S, Hassani S, Mardpour S, Sayahpour F, Vosough M, Ai J, Aghdami N, Hamidieh AA, Baharvand H. Extracellular vesicles derived from human embryonic stem cell‐MSCs ameliorate cirrhosis in thioacetamide‐induced chronic liver injury. J Cell Physiol 2018;233:9330-44. [DOI: 10.1002/jcp.26413] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
55 Roeb E. Matrix metalloproteinases and liver fibrosis (translational aspects). Matrix Biol. 2018;68-69:463-473. [PMID: 29289644 DOI: 10.1016/j.matbio.2017.12.012] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 11.2] [Reference Citation Analysis]
56 Allen J, Zhang J, Quickel MD, Kennett M, Patterson AD, Hankey-Giblin PA. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model. J Proteome Res 2018;17:3268-80. [PMID: 30091925 DOI: 10.1021/acs.jproteome.8b00379] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
57 Popov Y, Schuppan D. Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies. Hepatology. 2009;50:1294-1306. [PMID: 19711424 DOI: 10.1002/hep.23123] [Cited by in Crossref: 214] [Cited by in F6Publishing: 222] [Article Influence: 16.5] [Reference Citation Analysis]
58 Marsillach J, Ferré N, Camps J, Rull A, Beltran R, Joven J. Changes in the expression of genes related to apoptosis and fibrosis pathways in CCl4-treated rats. Mol Cell Biochem. 2008;308:101-109. [PMID: 17938867 DOI: 10.1007/s11010-007-9617-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
59 Borkham-Kamphorst E, Huss S, Van de Leur E, Haas U, Weiskirchen R. Adenoviral CCN3/NOV gene transfer fails to mitigate liver fibrosis in an experimental bile duct ligation model because of hepatocyte apoptosis. Liver Int 2012;32:1342-53. [PMID: 22698069 DOI: 10.1111/j.1478-3231.2012.02837.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
60 Hemmann S, Graf J, Roderfeld M, Roeb E. Expression of MMPs and TIMPs in liver fibrosis - a systematic review with special emphasis on anti-fibrotic strategies. J Hepatol. 2007;46:955-975. [PMID: 17383048 DOI: 10.1016/j.jhep.2007.02.003] [Cited by in Crossref: 303] [Cited by in F6Publishing: 297] [Article Influence: 20.2] [Reference Citation Analysis]
61 Li H, Zhang L, Cai N, Zhang B, Sun S. MicroRNA-494-3p prevents liver fibrosis and attenuates hepatic stellate cell activation by inhibiting proliferation and inducing apoptosis through targeting TRAF3. Ann Hepatol 2021;23:100305. [PMID: 33434689 DOI: 10.1016/j.aohep.2021.100305] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
62 Zinter MS, Delucchi KL, Kong MY, Orwoll BE, Spicer AS, Lim MJ, Alkhouli MF, Ratiu AE, McKenzie AV, McQuillen PS, Dvorak CC, Calfee CS, Matthay MA, Sapru A. Early Plasma Matrix Metalloproteinase Profiles. A Novel Pathway in Pediatric Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2019;199:181-9. [PMID: 30114376 DOI: 10.1164/rccm.201804-0678OC] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
63 Hu PF, Zhu YW, Zhong W, Chen YX, Lin Y, Zhang X, Yin C, Yue HY, Xie WF. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells. J Gastroenterol Hepatol. 2008;23:1917-1925. [PMID: 18761555 DOI: 10.1111/j.1440-1746.2008.05485.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
64 Atta HM. Reversibility and heritability of liver fibrosis: Implications for research and therapy. World J Gastroenterol 2015; 21(17): 5138-5148 [PMID: 25954087 DOI: 10.3748/wjg.v21.i17.5138] [Cited by in CrossRef: 30] [Cited by in F6Publishing: 33] [Article Influence: 4.3] [Reference Citation Analysis]
65 Gieling RG, Wallace K, Han YP. Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol. 2009;296:G1324-G1331. [PMID: 19342509 DOI: 10.1152/ajpgi.90564] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
66 Gieling RG, Burt AD, Mann DA. Fibrosis and cirrhosis reversibility - molecular mechanisms. Clin Liver Dis. 2008;12:915-937, xi. [PMID: 18984474 DOI: 10.1016/j.cld.2008.07.001] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
67 Salguero Palacios R, Roderfeld M, Hemmann S, Rath T, Atanasova S, Tschuschner A, Gressner OA, Weiskirchen R, Graf J, Roeb E. Activation of hepatic stellate cells is associated with cytokine expression in thioacetamide-induced hepatic fibrosis in mice. Lab Invest. 2008;88:1192-1203. [PMID: 18794850 DOI: 10.1038/labinvest.2008.91] [Cited by in Crossref: 95] [Cited by in F6Publishing: 93] [Article Influence: 6.8] [Reference Citation Analysis]
68 Geervliet E, Bansal R. Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases. Cells. 2020;9. [PMID: 32414178 DOI: 10.3390/cells9051212] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 9.5] [Reference Citation Analysis]
69 Hardjo M, Miyazaki M, Sakaguchi M, Masaka T, Ibrahim S, Kataoka K, Huh NH. Suppression of carbon tetrachloride-induced liver fibrosis by transplantation of a clonal mesenchymal stem cell line derived from rat bone marrow. Cell Transplant. 2009;18:89-99. [PMID: 19476212 DOI: 10.3727/096368909788237140] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
70 Nanda KS, Brady JJ, Murray BF, Sullivan O, Fearon U, McKenna MJ, Hegarty JE, O’Farrelly C, Ryan EJ. Elevated circulating osteoprotegerin and reduced matrix-metalloprotease-9 in post-menopausal women with chronic Hepatitis C virus infection. Cytokine. 2012;60:328-333. [PMID: 22863720 DOI: 10.1016/j.cyto.2012.07.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
71 Atta H, El-Rehany M, Roeb E, Abdel-Ghany H, Ramzy M, Gaber S. Mutant matrix metalloproteinase-9 reduces postoperative peritoneal adhesions in rats. Int J Surg 2016;26:58-63. [PMID: 26790972 DOI: 10.1016/j.ijsu.2015.12.065] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
72 Fowell AJ, Collins JE, Duncombe DR, Pickering JA, Rosenberg WM, Benyon RC. Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation. Biochem Biophys Res Commun. 2011;407:277-282. [PMID: 21300026 DOI: 10.1016/j.bbrc.2011.02.009] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
73 Madsen DH, Jürgensen HJ, Ingvarsen S, Melander MC, Vainer B, Egerod KL, Hald A, Rønø B, Madsen CA, Bugge TH, Engelholm LH, Behrendt N. Endocytic collagen degradation: a novel mechanism involved in protection against liver fibrosis. J Pathol 2012;227:94-105. [PMID: 22294280 DOI: 10.1002/path.3981] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.3] [Reference Citation Analysis]
74 Thiele ND, Wirth JW, Steins D, Koop AC, Ittrich H, Lohse AW, Kluwe J. TIMP-1 is upregulated, but not essential in hepatic fibrogenesis and carcinogenesis in mice. Sci Rep 2017;7:714. [PMID: 28386095 DOI: 10.1038/s41598-017-00671-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
75 Neaud V, Rosenbaum J. A red wine polyphenolic extract reduces the activation phenotype of cultured human liver myofibroblasts. World J Gastroenterol 2008; 14(14): 2194-2199 [PMID: 18407593 DOI: 10.3748/wjg.14.2194] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
76 Weiskirchen R. Hepatoprotective and Anti-fibrotic Agents: It's Time to Take the Next Step. Front Pharmacol. 2015;6:303. [PMID: 26779021 DOI: 10.3389/fphar.2015.00303] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 5.7] [Reference Citation Analysis]
77 Iredale JP. Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest. 2007;117:539-548. [PMID: 17332881 DOI: 10.1172/jci30542] [Cited by in Crossref: 552] [Cited by in F6Publishing: 302] [Article Influence: 36.8] [Reference Citation Analysis]
78 Wu Y, Lu S, Huang X, Liu Y, Huang K, Liu Z, Xu W, Zhu W, Hou J, Liu H, Zhang X. Targeting cIAPs attenuates CCl4-induced liver fibrosis by increasing MMP9 expression derived from neutrophils. Life Sci 2022;289:120235. [PMID: 34914932 DOI: 10.1016/j.lfs.2021.120235] [Reference Citation Analysis]
79 Rieder F, Bettenworth D, Imai J, Inagaki Y. Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology? Inflamm Intest Dis. 2016;1:41-49. [PMID: 29922656 DOI: 10.1159/000445135] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
80 Melgar-Lesmes P, Luquero A, Parra-Robert M, Mora A, Ribera J, Edelman ER, Jiménez W. Graphene-Dendrimer Nanostars for Targeted Macrophage Overexpression of Metalloproteinase 9 and Hepatic Fibrosis Precision Therapy. Nano Lett 2018;18:5839-45. [PMID: 30096241 DOI: 10.1021/acs.nanolett.8b02498] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
81 Kojo K, Ito Y, Eshima K, Nishizawa N, Ohkubo H, Yokomizo T, Shimizu T, Watanabe M, Majima M. BLT1 signalling protects the liver against acetaminophen hepatotoxicity by preventing excessive accumulation of hepatic neutrophils. Sci Rep 2016;6:29650. [PMID: 27404729 DOI: 10.1038/srep29650] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
82 Liu N, Zhang XL. Gene therapy for hepatic fibrosis. Shijie Huaren Xiaohua Zazhi 2008; 16(3): 284-288 [DOI: 10.11569/wcjd.v16.i3.284] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
83 van Zijl F, Mair M, Csiszar A, Schneller D, Zulehner G, Huber H, Eferl R, Beug H, Dolznig H, Mikulits W. Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene. 2009;28:4022-4033. [PMID: 19718050 DOI: 10.1038/onc.2009.253] [Cited by in Crossref: 124] [Cited by in F6Publishing: 119] [Article Influence: 9.5] [Reference Citation Analysis]
84 Yano H, Nishimiya D, Kawaguchi Y, Tamura M, Hashimoto R. Discovery of potent and specific inhibitors targeting the active site of MMP-9 from the engineered SPINK2 library. PLoS One 2020;15:e0244656. [PMID: 33373399 DOI: 10.1371/journal.pone.0244656] [Reference Citation Analysis]
85 Petreaca M, Martins-green M. Cell-ECM Interactions in Repair and Regeneration. Principles of Regenerative Medicine. Elsevier; 2011. pp. 19-65. [DOI: 10.1016/b978-0-12-381422-7.10002-1] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
86 Borkham-kamphorst E, Zimmermann HW, Gassler N, Bissels U, Bosio A, Tacke F, Weiskirchen R, Kanse SM. Factor VII activating protease (FSAP) exerts anti-inflammatory and anti-fibrotic effects in liver fibrosis in mice and men. Journal of Hepatology 2013;58:104-11. [DOI: 10.1016/j.jhep.2012.09.007] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
87 Török NJ. Recent advances in the pathogenesis and diagnosis of liver fibrosis. J Gastroenterol. 2008;43:315-321. [PMID: 18592147 DOI: 10.1007/s00535-008-2181-x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
88 Gupta DK, Singh N, Sahu DK. TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma. Cancer Growth Metastasis 2014;7:1-8. [PMID: 24741325 DOI: 10.4137/CGM.S14205] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
89 Zhang XP, Zhang F, Zhang ZL, Ma J, Kong DS, Ni GX, Wang AY, Chen WX, Lu Y, Zheng SZ. Acupuncture combined with curcumin disrupts platelet-derived growth factor β receptor/extracellular signal-regulated kinase signalling and stimulates extracellular matrix degradation in carbon tetrachloride-induced hepatic fibrosis in rats. Acupunct Med 2012;30:324-30. [PMID: 22763371 DOI: 10.1136/acupmed-2012-010167] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
90 Panakanti R, Pratap A, Yang N, Jackson JS, Mahato RI. Triplex forming oligonucleotides against type α1(I) collagen attenuates liver fibrosis induced by bile duct ligation. Biochem Pharmacol 2010;80:1718-26. [PMID: 20816672 DOI: 10.1016/j.bcp.2010.08.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
91 Yoo W, Lee J, Noh KH, Lee S, Jung D, Kabir MH, Park D, Lee C, Kwon KS, Kim JS, Kim S. Progranulin attenuates liver fibrosis by downregulating the inflammatory response. Cell Death Dis 2019;10:758. [PMID: 31591383 DOI: 10.1038/s41419-019-1994-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
92 Rabani V, Shahsavani M, Gharavi M, Piryaei A, Azhdari Z, Baharvand H. Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression. Cell Biol Int. 2010;34:601-605. [PMID: 20178458 DOI: 10.1042/cbi20090386] [Cited by in Crossref: 69] [Cited by in F6Publishing: 37] [Article Influence: 5.8] [Reference Citation Analysis]
93 Chen J, Chen L, Zern MA, Theise ND, Diehl AM, Liu P, Duan Y. The diversity and plasticity of adult hepatic progenitor cells and their niche. Liver Int 2017;37:1260-71. [PMID: 28135758 DOI: 10.1111/liv.13377] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
94 Düsterhöft S, Höbel K, Oldefest M, Lokau J, Waetzig GH, Chalaris A, Garbers C, Scheller J, Rose-John S, Lorenzen I, Grötzinger J. A disintegrin and metalloprotease 17 dynamic interaction sequence, the sweet tooth for the human interleukin 6 receptor. J Biol Chem 2014;289:16336-48. [PMID: 24790088 DOI: 10.1074/jbc.M114.557322] [Cited by in Crossref: 48] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
95 Schmitt J, Roderfeld M, Sabrane K, Zhang P, Tian Y, Mertens JC, Frei P, Stieger B, Weber A, Müllhaupt B, Roeb E, Geier A. Complement factor C5 deficiency significantly delays the progression of biliary fibrosis in bile duct-ligated mice. Biochem Biophys Res Commun 2012;418:445-50. [PMID: 22277671 DOI: 10.1016/j.bbrc.2012.01.036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
96 Atta H, El-Rehany M, Hammam O, Abdel-Ghany H, Ramzy M, Roderfeld M, Roeb E, Al-Hendy A, Raheim SA, Allam H. Mutant MMP-9 and HGF gene transfer enhance resolution of CCl4-induced liver fibrosis in rats: role of ASH1 and EZH2 methyltransferases repression. PLoS One. 2014;9:e112384. [PMID: 25380300 DOI: 10.1371/journal.pone.0112384] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
97 Salazar-Montes AM, Hernández-Ortega LD, Lucano-Landeros MS, Armendariz-Borunda J. New gene therapy strategies for hepatic fibrosis. World J Gastroenterol 2015; 21(13): 3813-3825 [PMID: 25852266 DOI: 10.3748/wjg.v21.i13.3813] [Cited by in CrossRef: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
98 Snowdon VK, Fallowfield JA. Models and mechanisms of fibrosis resolution. Alcohol Clin Exp Res. 2011;35:794-799. [PMID: 21284668 DOI: 10.1111/j.1530-0277.2010.01400.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
99 van Deventer HW, Wu QP, Bergstralh DT, Davis BK, O'Connor BP, Ting JP, Serody JS. C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9. Am J Pathol 2008;173:253-64. [PMID: 18535183 DOI: 10.2353/ajpath.2008.070732] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.3] [Reference Citation Analysis]
100 Meurer SK, Karsdal MA, Weiskirchen R. Advances in the clinical use of collagen as biomarker of liver fibrosis. Expert Rev Mol Diagn 2020;20:947-69. [PMID: 32865433 DOI: 10.1080/14737159.2020.1814746] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
101 Salunkhe SA, Chitkara D, Mahato RI, Mittal A. Lipid based nanocarriers for effective drug delivery and treatment of diabetes associated liver fibrosis. Adv Drug Deliv Rev 2021;173:394-415. [PMID: 33831474 DOI: 10.1016/j.addr.2021.04.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Iaia N, Rossin D, Sottero B, Venezia I, Poli G, Biasi F. Efficacy of theobromine in preventing intestinal CaCo-2 cell damage induced by oxysterols. Archives of Biochemistry and Biophysics 2020;694:108591. [DOI: 10.1016/j.abb.2020.108591] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
103 Osawa Y, Hoshi M, Yasuda I, Saibara T, Moriwaki H, Kozawa O. Tumor necrosis factor-α promotes cholestasis-induced liver fibrosis in the mouse through tissue inhibitor of metalloproteinase-1 production in hepatic stellate cells. PLoS One 2013;8:e65251. [PMID: 23755201 DOI: 10.1371/journal.pone.0065251] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
104 Huang HC, Ho HL, Chang CC, Chuang CL, Pun CK, Lee FY, Huang YH, Hou MC, Hsu SJ. Matrix metalloproteinase-9 inhibition or deletion attenuates portal hypertension in rodents. J Cell Mol Med 2021;25:10073-87. [PMID: 34647412 DOI: 10.1111/jcmm.16940] [Reference Citation Analysis]
105 Yada A, Iimuro Y, Uyama N, Uda Y, Okada T, Fujimoto J. Splenectomy attenuates murine liver fibrosis with hypersplenism stimulating hepatic accumulation of Ly-6C(lo) macrophages. J Hepatol. 2015;63:905-916. [PMID: 26022691 DOI: 10.1016/j.jhep.2015.05.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
106 Ebrahimi H, Naderian M, Sohrabpour AA. New Concepts on Reversibility and Targeting of Liver Fibrosis; A Review Article. Middle East J Dig Dis. 2018;10:133-148. [PMID: 30186577 DOI: 10.15171/mejdd.2018.103] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.8] [Reference Citation Analysis]
107 Chiang DJ, Pritchard MT, Nagy LE. Obesity, diabetes mellitus, and liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2011;300:G697-G702. [PMID: 21350183 DOI: 10.1152/ajpgi.00426.2010] [Cited by in Crossref: 106] [Cited by in F6Publishing: 100] [Article Influence: 9.6] [Reference Citation Analysis]
108 Hong SW, Jung KH, Lee HS, Zheng HM, Choi MJ, Lee C, Hong SS. Suppression by fucoidan of liver fibrogenesis via the TGF-β/Smad pathway in protecting against oxidative stress. Biosci Biotechnol Biochem 2011;75:833-40. [PMID: 21597183 DOI: 10.1271/bbb.100599] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]